TRPM4 (transient receptor potential melastatin 4) is a Ca
2+-activated, voltage-dependent, nonselective monovalent cation channel that converts intracellular Ca
2+ signals into membrane depolarization and thereby regulates Ca
2+ entry through other Ca
2+-permeable pathways
[1][2]. Mechanistically, TRPM4 activity is strongly controlled by phosphatidylinositol 4,5-bisphosphate (PIP
2), which enhances channel Ca
2+ sensitivity, shifts voltage dependence, and counteracts channel desensitization, linking TRPM4 to phospholipase C-associated signaling processes
[1]. Through its effects on membrane potential and Ca
2+ homeostasis, TRPM4 participates in physiological functions including electrical signaling, immune responses, insulin secretion, and cardiovascular regulation
[2][3]. In disease contexts, altered TRPM4 function has been associated with cardiac conduction disorders and other pathophysiological conditions in which dysregulated cellular excitability contributes to disease progression
[2]. Compared with the closely related isoform TRPM5, TRPM4 shares the characteristic of being a Ca
2+-activated monovalent cation channel but differs in tissue distribution and physiological roles, making isoform-specific interpretation important in experimental studies
[3][4]. For experimental applications, pharmacological inhibition of TRPM4 has become a useful strategy for investigating channel-dependent signaling and electrophysiological mechanisms, and several small-molecule inhibitors have been evaluated for their ability to modulate TRPM4 activity in vitro and in vivo
[5].